Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Trial Phase 3 Completed Oct. 1, 2014

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Trial Phase 3 Completed Oct. 1, 2014

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Trial Phase 3 Completed Oct. 1, 2014

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

Trial Phase 3 Completed Oct. 1, 2014

Molecular Epidemiology of Parkinson's Disease

Trial N/A Completed Sept. 28, 2014

Farming and Movement Evaluation Study (FAME)

Trial N/A Completed Sept. 28, 2014

Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease

Trial N/A Unknown Sept. 25, 2014

Neuromodulation on Motor Function in Parkinson's Disease

Trial N/A Unknown Sept. 25, 2014

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Trial N/A Completed Sept. 24, 2014

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Trial Phase 3 Completed Sept. 24, 2014

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

Trial N/A Completed Sept. 24, 2014

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

Trial N/A Completed Sept. 24, 2014

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

Trial Phase 3 Completed Sept. 24, 2014

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

Trial N/A Completed Sept. 24, 2014

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Trial Phase 3 Completed Sept. 24, 2014

Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease

Trial Early Phase 1 Completed Sept. 17, 2014

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

Trial N/A Completed Sept. 16, 2014

Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming

Trial N/A Completed Sept. 14, 2014

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

Trial N/A Completed Sept. 10, 2014

A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease

Trial N/A Unknown Sept. 10, 2014